INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 440m ago
HOUSE PTR40m ago
SEC 13F40m ago
ROBINHOOD CHAIN40m ago
LJ
Corporate insider

Larosa Joseph J

EVP General Counsel and SecretCIK 0001238303

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells0 / 2
Max Insider Score49
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
26
LJ
Larosa Joseph JEVP General Counsel and Secret
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M$4.69M
12.3K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    REGENERON PHARMACEUTICALS, INC.Officer · Form 144 · Nov 1, 2026
26
LJ
Larosa Joseph JEVP General Counsel and Secret
REGNREGENERON PHARMACEUTICALS, INC.
Tax withholding
F
$8.26M
8,686 sh
Nov 2, 2026
Nov 4, 2026
traded Nov 2, 2026
+2d
SEC FORM 4

Evidence

49
LJ
Larosa Joseph JEVP General Counsel and Secret
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$3.80M
3,939 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

42
LJ
Larosa Joseph JEVP General Counsel and Secret
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$509K
527 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

9
LJ
Larosa Joseph JEVP General Counsel and Secret
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M—
12.3K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence